DECEMBER 202319AccuPulse MedicalAtrial Fibrillation Treatment Made Easysources employ time-dependent conductive heating and cooling to ablate all tissue types indiscriminately, PFA selectively ablates cardiac tissues non-thermally by creating nanoscale pores in cell membranes and extracting their cellular content, which is a much safer and more efficient method. The PFA also limits fluorocarbon exposure to patients, which is typically associated with the procedure, considerably reducing the risks.Most electrophysiology labs have various discrete systems like ablation catheters, 3D mapping systems, and recording systems. AccuPulse is including an intracardiac echocardiography (ICE) capability, which is currently lacking, to its integrated system and replacing five separate pieces of equipment with one.AccuPulse's integrated PFA system solves a major problem electrophysiology labs face with AF treatment today. It is difficult for hospitals to cut costs with multiple equipment in use, but with AccuPulse's novel technology, the EP labs invest in a single piece of equipment. Its hybrid impedance and magnetic system allow for more accurate localization and visualization of catheters within the heart and help doctors conclude the procedure faster, making it cost-effective for hospitals.AccuPulse ensures its system is user-friendly, making it easy for physicians to carry out the procedure. It even plans to develop an IoT infrastructure that allows multiple doctors to remotely view clinical procedures.AccuPulse, despite being a startup, has established a distinct market niche in the electrophysiology industry within a relatively short period. Its team is committed to becoming a global leader in the cardiac electrophysiology industry, taking advantage of the Chinese and American engineering cultures. Its engineering team is based in Utah, with engineers across the US as well as in China.Its expert team, led and supported by multiple electrophysiological experts and top scientists, is devoted to providing the healthcare sector with the best innovations in AF treatment. The med-tech industry will witness a revolutionary change as AccuPulse enters its next phase. We intend to bring in a completely self-contained system that is an inexpensive alternative to traditional AF treatment options. It is to be manufactured in China and deployed all over Asia
< Page 9 | Page 11 >